Subtype
Colon Neoplasm
CI-CAN-00004992Explore in graph →
Non-malignant271 active trials5 approved drugs17 evidence items
Loading cancer entity…
Subtype
CI-CAN-00004992Explore in graph →
Clinical trials
1,559 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02355379 | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over(ADAGE) | unknown | Phase 3 | 774 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT02974556 | Proactive Management of Endoperitoneal Spread in Colonic Cancer(PROMENADE) | unknown | Phase 3 | 140 | University of Roma La SapienzaOTHER |
| 1 |
| May 6, 2023 |
| clinicaltrials |
| NCT04167436 | Fit for Surgery. Multimodal Prehabilitation in Colorectal Cancer Patients | unknown | Phase 2 / Phase 3 | 48 | Zealand University HospitalOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT05074966 | The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts | unknown | Phase 3 | 314 | Chinese Academy of Medical SciencesOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT03716518 | Herbal Treatment to Improve Chemotherapy Delivery(HATCHED) | unknown | Phase 3 | 400 | Xiyuan Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | Jan 12, 2021 | clinicaltrials |
| NCT04089631 | Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation(CIRCULATE) | unknown | Phase 3 | 4,812 | Technische Universität DresdenOTHER | 1 | Aug 6, 2020 | clinicaltrials |
| NCT04416854 | The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer | unknown | Phase 3 | 627 | Fudan UniversityOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04303429 | Adjuvant Chemotherapy in High Risk Stage II Colon Cancer | unknown | Phase 3 | 962 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Apr 8, 2020 | clinicaltrials |
| NCT02928692 | Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium(MAPOCD) | unknown | Phase 3 | 750 | RenJi HospitalOTHER | 1 | Jan 28, 2020 | clinicaltrials |
| NCT01092481 | Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy | unknown | Phase 3 | 1,580 | Samsung Medical CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT03686254 | The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM | unknown | Phase 2 / Phase 3 | 160 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT02526836 | Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer | unknown | Phase 2 / Phase 3 | 40 | Mansoura UniversityOTHER | 2 | Aug 16, 2018 | clinicaltrials |
| NCT03606863 | Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS | unknown | Phase 3 | 200 | Antonio Arroyo SebastianOTHER | 1 | Jul 31, 2018 | clinicaltrials |
| NCT02912052 | Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis(PEPCORLI) | unknown | Phase 3 | 240 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT02882269 | Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer | unknown | Phase 2 / Phase 3 | 400 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Aug 30, 2016 | clinicaltrials |
| NCT02852915 | Laparoscopic Surgery for T4 Tumor of the Colon Cancer | unknown | Phase 3 | 1,960 | LI XIN-XIANGOTHER | 0 | Aug 4, 2016 | clinicaltrials |
| NCT02682589 | Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer(OLCMECC) | unknown | Phase 3 | 1,080 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT02777437 | Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer | unknown | Phase 2 / Phase 3 | 1,960 | Fudan UniversityOTHER | 0 | May 19, 2016 | clinicaltrials |
| NCT02598414 | The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery | unknown | Phase 2 / Phase 3 | 102 | Acibadem UniversityOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | unknown | Phase 2 / Phase 3 | 360 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 3, 2015 | clinicaltrials |
| NCT02280278 | Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy | unknown | Phase 3 | 550 | Sun Yat-sen UniversityOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01589146 | ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.(PRO-LAPS I) | unknown | Phase 3 | 400 | University Of PerugiaOTHER | 1 | May 1, 2012 | clinicaltrials |
| NCT00337389 | Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. | unknown | Phase 3 | 1,200 | Mast Therapeutics, Inc.INDUSTRY | 2 | Nov 19, 2007 | clinicaltrials |
| NCT00387842 | COlon Cancer Laparoscopic or Open Resection | unknown | Phase 3 | 1,200 | Erasmus Medical CenterOTHER | 0 | Oct 13, 2006 | clinicaltrials |
| NCT00295035 | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer | unknown | Phase 3 | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Feb 22, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Jul 8, 2024source: clinicaltrials